-20% OFF
Purchase & earn 1,290 Pep Points!

Cagrilintide 10mg

Original price was: $129.00.Current price is: $129.00. $103.20

Cagrilintide 10mg is a long-acting amylin analogue being studied extensively in metabolic and appetite-regulation research.

Amylin is a naturally occurring hormone released alongside insulin after food intake and participates in signaling related to satiety, gastric activity, and energy intake. Cagrilintide was designed to provide prolonged activity at amylin-related receptors, making it particularly interesting to researchers studying appetite regulation and metabolic signaling.

Cagrilintide has attracted substantial attention both as a standalone compound and in combination with semaglutide in the investigational therapy known as CagriSema. Phase 3 research has evaluated cagrilintide in people with overweight and obesity, while additional clinical-development programs continue to examine the broader potential of amylin-based therapies. 

CDE10
Trust Badge
Guaranteed safe & secure checkout

Description

Cagrilintide 10mg is a long-acting amylin analogue being studied extensively in metabolic and appetite-regulation research.

Amylin is a naturally occurring hormone released alongside insulin after food intake and participates in signaling related to satiety, gastric activity, and energy intake. Cagrilintide was designed to provide prolonged activity at amylin-related receptors, making it particularly interesting to researchers studying appetite regulation and metabolic signaling.

Cagrilintide has attracted substantial attention both as a standalone compound and in combination with semaglutide in the investigational therapy known as CagriSema. Phase 3 research has evaluated cagrilintide in people with overweight and obesity, while additional clinical-development programs continue to examine the broader potential of amylin-based therapies. 

Common research areas: amylin signaling, appetite regulation, satiety pathways, metabolic signaling, energy intake, and body-weight regulation.

Product Strength: 10mg

As of August 2026, cagrilintide remains an investigational compound rather than an FDA-approved standalone medication. Novo Nordisk continues to list cagrilintide within its research and development pipeline. 

Related products

Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
  • Image
  • SKU
  • Rating
  • Price
  • Stock
  • Add to cart
Click outside to hide the comparison bar
Compare